There is much debate about whether pharmaceutical companies will be able to harness the exponential growth of social media.
Most savvy businesses now have a presence on Facebook and Twitter, but drug manufacturers find their hands bound by privacy and advertising restrictions. No doubt they are searching for breakout, attention-grabbing efforts beyond the usual bland self-promotion.
Surely they know that consumers most desire helpful information and value. But can they deliver it?